Sichuan Guoguang Agrochemical Co., Ltd. (002749.SZ)
Chengdu, CN
Established in Chengdu, China, in 1984, Sichuan Guoguang Agrochemical Co., Ltd. is a key enterprise specializing in the agricultural chemicals sector. The company's core operations involve the research, development, manufacturing, marketing, and distribution of a diverse range of agrochemical products and raw materials, primarily serving the Chinese market. Its comprehensive product portfolio includes plant growth regulators, various fertilizers, fungicides, insecticides, biological pesticides, and herbicides. Beyond its domestic presence, the firm also has a significant international footprint, exporting its specialized agricultural solutions to numerous countries worldwide, such as the United States, Japan, Korea, Malaysia, Vietnam, Pakistan, and Egypt.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.20% | -5.10% | -12.76% | -21.19% | -20.44% | -16.29% | -24.21% | +2.42% | +11.11% | -10.83% | +63.73% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+3.5% Q1'26: -1.2% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-15.0% Q1'26: -23.5% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+16.1% Q1'26: -11.1% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+20.8% ★ Q1'26: +20.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+33.6% ★ Q1'26: +23.7% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.1% Q1'26: -1.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.15× ★ Q1'26: 0.15× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
605.02M
est: 619.00M (-2.3%)
|
614.26M
est: 1.13B (-45.4%)
|
737.32M
est: 736.00M (+0.2%)
|
865.42M
est: 883.00M (-2.0%)
|
865.42M
est: 883.00M (-2.0%)
|
1.01B
est: 1.03B (-1.7%)
|
1.01B
est: 1.03B (-1.7%)
|
1.16B
est: 1.13B (+2.7%)
|
1.16B
est: 1.13B (+2.7%)
|
1.36B
est.
|
1.36B
est.
|
1.36B
est: 1.61B (-15.4%)
|
1.36B
est: 1.61B (-15.4%)
|
1.86B
est: 1.98B (-6.1%)
|
1.65B
est: 1.98B (-16.8%)
|
1.99B
est: 2.09B (-5.1%)
|
2.06B
est: 2.29B (-10.1%)
|
2.29B
2.24B – 2.34B
+0.1% YoY
|
2.61B
2.50B – 2.71B
+13.8% YoY
|
2.62B
2.54B – 2.71B
+0.6% YoY
|
| EBITDA |
161.68M
est: 195.98M (-17.5%)
|
176.29M
est: 356.50M (-50.6%)
|
222.43M
est: 233.02M (-4.5%)
|
271.69M
est: 193.97M (+40.1%)
|
271.69M
est: 279.56M (-2.8%)
|
241.85M
est: 226.70M (+6.7%)
|
241.85M
est: 326.74M (-26.0%)
|
257.98M
est: 248.01M (+4.0%)
|
257.98M
est: 357.45M (-27.8%)
|
298.31M
est.
|
429.95M
est.
|
306.99M
est: 352.79M (-13.0%)
|
306.99M
est: 508.47M (-39.6%)
|
439.04M
est: 627.15M (-30.0%)
|
226.22M
est: 627.15M (-63.9%)
|
512.01M
est: 662.98M (-22.8%)
|
503.12M
est: 724.08M (-30.5%)
|
725.03M
709.56M – 740.51M
+0.1% YoY
|
824.76M
790.39M – 859.14M
+13.8% YoY
|
829.99M
803.54M – 856.43M
+0.6% YoY
|
| EBIT |
156.98M
est: 173.72M (-9.6%)
|
171.61M
est: 316.00M (-45.7%)
|
217.46M
est: 206.55M (+5.3%)
|
266.28M
est: 159.33M (+67.1%)
|
266.28M
est: 247.81M (+7.5%)
|
233.04M
est: 186.22M (+25.1%)
|
233.04M
est: 289.62M (-19.5%)
|
215.93M
est: 203.72M (+6.0%)
|
215.93M
est: 316.85M (-31.8%)
|
245.04M
est.
|
381.11M
est.
|
259.57M
est: 289.79M (-10.4%)
|
259.57M
est: 450.71M (-42.4%)
|
373.00M
est: 555.91M (-32.9%)
|
165.99M
est: 555.91M (-70.1%)
|
448.61M
est: 587.67M (-23.7%)
|
427.56M
est: 641.83M (-33.4%)
|
642.67M
628.96M – 656.39M
+0.1% YoY
|
731.08M
700.61M – 761.54M
+13.8% YoY
|
735.71M
712.26M – 759.15M
+0.6% YoY
|
| Net Income |
133.81M
est: 128.31M (+4.3%)
|
139.25M
est: 220.31M (-36.8%)
|
185.30M
est: 199.57M (-7.2%)
|
234.59M
est: 224.59M (+4.5%)
|
234.59M
est: 223.90M (+4.8%)
|
201.13M
est: 270.05M (-25.5%)
|
201.13M
est: 269.22M (-25.3%)
|
170.84M
est: 216.92M (-21.2%)
|
170.84M
est: 216.25M (-21.0%)
|
216.46M
est.
|
215.79M
est.
|
206.17M
est: 262.51M (-21.5%)
|
206.17M
est: 261.70M (-21.2%)
|
302.04M
est: 321.39M (-6.0%)
|
113.59M
est: 321.39M (-64.7%)
|
367.03M
est: 309.91M (+18.4%)
|
312.21M
est: 355.83M (-12.3%)
|
340.52M
326.42M – 354.63M
-4.3% YoY
|
378.78M
363.09M – 394.47M
+11.2% YoY
|
359.65M
344.75M – 374.55M
-5.1% YoY
|
| SGA |
151.75M
est: 122.59M (+23.8%)
|
150.75M
est: 222.99M (-32.4%)
|
145.13M
est: 145.76M (-0.4%)
|
170.89M
est: 76.68M (+122.9%)
|
170.89M
est: 174.87M (-2.3%)
|
195.81M
est: 89.61M (+118.5%)
|
195.81M
est: 204.38M (-4.2%)
|
239.51M
est: 98.04M (+144.3%)
|
239.51M
est: 223.59M (+7.1%)
|
117.92M
est.
|
268.94M
est.
|
294.39M
est: 139.46M (+111.1%)
|
294.39M
est: 318.05M (-7.4%)
|
345.49M
est: 392.29M (-11.9%)
|
331.42M
est: 392.29M (-15.5%)
|
390.14M
est: 414.70M (-5.9%)
|
390.98M
est: 452.92M (-13.7%)
|
453.51M
443.83M – 463.19M
+0.1% YoY
|
515.89M
494.39M – 537.39M
+13.8% YoY
|
519.16M
502.62M – 535.70M
+0.6% YoY
|
| EPS |
0.33
est: 0.28 (+18.1%)
|
0.33
est: 0.48 (-31.2%)
|
0.43
est: 0.43 (-1.1%)
|
0.55
est: 0.49 (+12.8%)
|
0.55
est: 0.49 (+12.8%)
|
0.47
est: 0.59 (-19.8%)
|
0.47
est: 0.59 (-19.8%)
|
0.40
est: 0.47 (-15.1%)
|
0.40
est: 0.47 (-15.1%)
|
0.47
est.
|
0.47
est.
|
0.48
est: 0.57 (-15.8%)
|
0.48
est: 0.57 (-15.8%)
|
0.70
est: 0.70 (+0.0%)
|
0.26
est: 0.70 (-62.9%)
|
0.82
est: 0.68 (+21.5%)
|
0.68
est: 0.78 (-12.3%)
|
0.74
0.71 – 0.77
-4.3% YoY
|
0.83
0.79 – 0.86
+11.2% YoY
|
0.78
0.75 – 0.82
-5.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-28 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-27 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-15 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 5/5 | 5/5 | 3/5 | 2/5 | 2/5 |
| 2026-05-08 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 5/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jie He | Chairman & President | — | male |
| Lei Yang | Chief Financial Officer | — | male |
| Ming Yan | Secretary of the Board | — | male |
| Pan Dao Wu | Vice President | — | male |
| Peng He | VP& Director | — | male |
| Tao Zou | Vice President & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002749.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
